Learn more

LETI LAB

Overview
  • Total Patents
    47
  • GoodIP Patent Rank
    232,765
About

LETI LAB has a total of 47 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PNEUMAGEN LTD, HEAT BIOLOGICS INC and INST MASSONE S A.

Patent filings per year

Chart showing LETI LABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Berrens Lubertus 15
#2 Requena Rolania Jose Maria 8
#3 Soto Alvarez Manuel 8
#4 Bedate Alonso Carlos 7
#5 Alonso Bedate Carlos 6
#6 Alonso Carlos Bedate 4
#7 Gonzales Romano Maria Leticia 4
#8 Gallego Camara Maria Teresa 4
#9 Bedate Carlos Alonso 3
#10 Alvarez Manuel Soto 2

Latest patents

Publication Filing date Title
WO0181388A1 Composition containing leishmania lip2a
US6525186B2 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained
MXPA01006548A Chimeric gene encoding the antigenic determinants of four proteins of l. infantum.
US6458359B1 Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans
CA2256125A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, useful for serologic diagnosis of canine leishmaniasis and protein obtained
CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
IL135881D0 Tolerogenic fragments of natural allergens
DE122005000035I1 PROCESS FOR CLEANING WAESSER EXTRACTS CONTAINING ALLERGENIC PROTEINS, EXTRACTS OBTAINED THEREOF, AND THEIR USE
WO9406821A1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
NL8900652A Primary toxic substances or allergens, isolable from vegetable material, and methods for the preparation and use thereof.
EP0377229A1 Use of specific properties of allergens from animal sources and methods for their isolation